ICON PLC (ICLR) stock: key figures, P/E, revenue and dividend
Health Care · Ireland · ISIN IE0005711209
ICON PLC financials
| Fiscal year | 2025 |
|---|---|
| Revenue | 8.25 bn USD |
| Gross profit | 2.18 bn USD |
| Operating income | 442.85 m USD |
| EBIT | 442.00 m USD |
| Net income | 229.34 m USD |
| Diluted EPS – continuing operations | 2.90 USD |
Full history since 1993, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About ICON PLC
ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical studies. It also provides clinical development services, including all phases of development, peri and post approval, data solutions, and site and patient access services; clinical trial management, consulting, contract staffing, data solutions, and laboratory services; and commercial services comprising clinical development strategy, planning and trial design, full study execution, and post-market commercialization. In addition, the company offers testing services comprising bioanalytical, biomarker, vaccine, good manufacturing practice, and central laboratory services, as well as full-service and functional service partnerships to customers. Further, the company provides adaptive trials, cardiac safety solutions, clinical and scientific operations, consulting and advisory, commercial positioning, decentralized and hybrid clinical trials, early clinical, medical imaging, real world intelligence, site and patient, and strategic solutions. Additionally, it provides therapeutics for cardiovascular, central nervous system, endocrine and metabolic disorders, hepatology, infectious diseases, internal medicine immunology, and oncology. It serves pharmaceutical, biotechnology, and medical device industries, as well as government and public health organizations. ICON Public Limited Company was incorporated in 1989 and is headquartered in Dublin, Ireland.
More stocks
- Grace Fabric Technology Co Ltd (603256.SS)
- James Hardie Industries PLC (JHX.AX)
- Piraeus Bank SA (TPEIR.AT)
- Ningbo Deye Technology Co Ltd (605117.SS)
- ARES CAPITAL CORP (ARCC)
- STRABAG SE (STR.VI)
- Banque Cantonale Vaudoise (BCVN.SW)
- GlobalWafers Co Ltd (6488.TWO)
- Daifuku Co Ltd (6383.T)
- Nidec Corp (6594.T)
- Telecom Italia SpA (TIT.MI)
- HALOZYME THERAPEUTICS, INC. (HALO)
Not investment advice. All data without warranty, price as of 14.10.2026. Details in the risk notice.